In downstream processing, buffers maintain defined purification conditions, control a protein's ionization state as necessary for column chromatography, and stabilize the protein while maintaining its functional characteristics.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biopharmaceutical Buffers industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Sterile Buffer
Non-sterile Buffer
Market Segment by Product Application
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other
Finally, the report provides detailed profile and data information analysis of leading company.
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton
and Dickinson and Company
GEA
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biopharmaceutical Buffers consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biopharmaceutical Buffers market by identifying its various subsegments.
3.Focuses on the key global Biopharmaceutical Buffers manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biopharmaceutical Buffers with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biopharmaceutical Buffers submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biopharmaceutical Buffers Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biopharmaceutical Buffers Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biopharmaceutical Buffers Segment by Type
2.1.1 Sterile Buffer
2.1.2 Non-sterile Buffer
2.2 Market Analysis by Application
2.2.1 Recombinant Proteins
2.2.2 Monoclonal Antibodies
2.2.3 Antibiotics
2.2.4 Probiotics
2.2.5 Other
2.3 Global Biopharmaceutical Buffers Market Comparison by Regions (2017-2027)
2.3.1 Global Biopharmaceutical Buffers Market Size (2017-2027)
2.3.2 North America Biopharmaceutical Buffers Status and Prospect (2017-2027)
2.3.3 Europe Biopharmaceutical Buffers Status and Prospect (2017-2027)
2.3.4 China Biopharmaceutical Buffers Status and Prospect (2017-2027)
2.3.5 Japan Biopharmaceutical Buffers Status and Prospect (2017-2027)
2.3.6 Southeast Asia Biopharmaceutical Buffers Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Buffers Industry Impact
2.5.1 Biopharmaceutical Buffers Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biopharmaceutical Buffers Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biopharmaceutical Buffers Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biopharmaceutical Buffers Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biopharmaceutical Buffers Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biopharmaceutical Buffers Manufacturer Market Share
3.5 Top 10 Biopharmaceutical Buffers Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biopharmaceutical Buffers Market
3.7 Key Manufacturers Biopharmaceutical Buffers Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Biopharmaceutical Buffers Industry Key Manufacturers
4.1 GE Healthcare
4.1.1 Compan Detail
4.1.2 GE Healthcare Biopharmaceutical Buffers Product Introduction, Application and Specification
4.1.3 GE Healthcare 159 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GE Healthcare News
4.2 Thermo Fisher Scientific
4.2.1 Compan Detail
4.2.2 Thermo Fisher Scientific Biopharmaceutical Buffers Product Introduction, Application and Specification
4.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GE Healthcare News
4.3 Danaher Corporation
4.3.1 Compan Detail
4.3.2 Danaher Corporation Biopharmaceutical Buffers Product Introduction, Application and Specification
4.3.3 Danaher Corporation Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Danaher Corporation News
4.4 Sartorius StedimBiotech
4.4.1 Compan Detail
4.4.2 Sartorius StedimBiotech Biopharmaceutical Buffers Product Introduction, Application and Specification
4.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Sartorius StedimBiotech News
4.5 Merck
4.5.1 Compan Detail
4.5.2 Sartorius StedimBiotech Biopharmaceutical Buffers Product Introduction, Application and Specification
4.5.3 Merck Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck News
4.6 Eppendorf
4.6.1 Compan Detail
4.6.2 Eppendorf Biopharmaceutical Buffers Product Introduction, Application and Specification
4.6.3 Eppendorf Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Eppendorf News
4.7 Roche
4.7.1 Compan Detail
4.7.2 Roche Biopharmaceutical Buffers Product Introduction, Application and Specification
4.7.3 Roche Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Nova Biomedicals
4.8.1 Compan Detail
4.8.2 Nova Biomedicals Biopharmaceutical Buffers Product Introduction, Application and Specification
4.8.3 Nova Biomedicals Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Nova Biomedicals News
4.9 Lonza
4.9.1 Compan Detail
4.9.2 Lonza Biopharmaceutical Buffers Product Introduction, Application and Specification
4.9.3 Lonza Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Lonza News
4.10 Becton
4.10.1 Compan Detail
4.10.2 Becton Biopharmaceutical Buffers Product Introduction, Application and Specification
4.10.3 Becton Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Becton News
4.11 and Dickinson and Company
4.11.1 Compan Detail
4.11.2 and Dickinson and Company Biopharmaceutical Buffers Product Introduction, Application and Specification
4.11.3 and Dickinson and Company Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 and Dickinson and Company News
4.12 GEA
4.12.1 Compan Detail
4.12.2 GEA Biopharmaceutical Buffers Product Introduction, Application and Specification
4.12.3 GEA Biopharmaceutical Buffers Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 GEA News
5 Global Biopharmaceutical Buffers Market Segment by Big Type
5.1 Global Biopharmaceutical Buffers Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Biopharmaceutical Buffers Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Biopharmaceutical Buffers Revenue and Market Share by Big Type (2017-2022)
5.2 Sterile Buffer Sales Growth Rate and Price
5.2.1 Global Sterile Buffer Sales Growth Rate (2017-2022)
5.2.2 Global Sterile Buffer Price (2017-2022)
5.3 Non-sterile Buffer Sales Growth Rate and Price
5.3.1 Global Non-sterile Buffer Sales Growth Rate (2017-2022)
5.3.2 Global Non-sterile Buffer Price (2017-2022)
6 Global Biopharmaceutical Buffers Market Segment by Big Application
6.1 Global Biopharmaceutical Buffers Sales Market Share by Big Application (2017-2022)
6.2 Recombinant Proteins Sales Growth Rate (2017-2022)
6.3 Monoclonal Antibodies Sales Growth Rate (2017-2022)
6.4 Antibiotics Sales Growth Rate (2017-2022)
6.5 Probiotics Sales Growth Rate (2017-2022)
6.6 Other Sales Growth Rate (2017-2022)
7 Global Biopharmaceutical Buffers Forecast
7.1 Global Biopharmaceutical Buffers Revenue, Sales and Growth Rate (2022-2027)
7.2 Biopharmaceutical Buffers Market Forecast by Regions (2022-2027)
7.2.1 North America Biopharmaceutical Buffers Market Forecast (2022-2027)
7.2.2 Europe Biopharmaceutical Buffers Market Forecast (2022-2027)
7.2.3 China Biopharmaceutical Buffers Market Forecast (2022-2027)
7.2.4 Japan Biopharmaceutical Buffers Market Forecast (2022-2027)
7.2.5 Southeast Asia Biopharmaceutical Buffers Market Forecast (2022-2027)
7.2.6 Other Regions Biopharmaceutical Buffers Market Forecast (2022-2027)
7.3 Biopharmaceutical Buffers Market Forecast by Type (2022-2027)
7.3.1 Global Biopharmaceutical Buffers Sales Forecast by Type (2022-2027)
7.3.2 Global Biopharmaceutical Buffers Market Share Forecast by Type (2022-2027)
7.4 Biopharmaceutical Buffers Market Forecast by Application (2022-2027)
7.4.1 Global Biopharmaceutical Buffers Sales Forecast by Application (2022-2027)
7.4.2 Global Biopharmaceutical Buffers Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Biopharmaceutical Buffers Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Biopharmaceutical Buffers Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Biopharmaceutical Buffers
Figure Market Concentration Ratio and Market Maturity Analysis of Biopharmaceutical Buffers
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biopharmaceutical Buffers Market Size by Big Type
Figure Global Market Share of Biopharmaceutical Buffers by Big Type in 2021
Figure Sterile Buffer Picture (2017-2022)
Global Biopharmaceutical Buffers Market Size by Big Application
Table Global Biopharmaceutical Buffers Market Size by Application
Figure Global Biopharmaceutical Buffers Market Share by Big Application in 2021
Figure Recombinant Proteins Picture
Figure Monoclonal Antibodies Picture
Figure Antibiotics Picture
Figure Probiotics Picture
Figure Other Picture
Table Global Biopharmaceutical Buffers Comparison by Regions (M USD) (2017-2027)
Figure Global Biopharmaceutical Buffers Market Size (Million US$) (2017-2027)
Figure North America Biopharmaceutical Buffers Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biopharmaceutical Buffers Revenue (Million US$) Growth Rate (2017-2027)
Figure China Biopharmaceutical Buffers Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Biopharmaceutical Buffers Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Biopharmaceutical Buffers Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biopharmaceutical Buffers Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biopharmaceutical Buffers Sales by Manufacturer (2017-2022)
Figure Global Biopharmaceutical Buffers Sales Market Share by Manufacturer in 2021
Table Global Biopharmaceutical Buffers Revenue by Manufacturer (2017-2022)
Figure Global Biopharmaceutical Buffers Revenue Market Share by Manufacturer in 2021
Table Global Biopharmaceutical Buffers Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biopharmaceutical Buffers Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biopharmaceutical Buffers Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biopharmaceutical Buffers Market
Table Key Manufacturers Biopharmaceutical Buffers Product Type
Table Mergers & Acquisitions Planning
Table GE Healthcare Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of GE Healthcare
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Thermo Fisher Scientific Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Thermo Fisher Scientific
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Thermo Fisher Scientific Recent Development
Table Danaher Corporation Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Danaher Corporation
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Danaher Corporation Main Business
Table Danaher Corporation Recent Development
Table Sartorius StedimBiotech Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Sartorius StedimBiotech
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sartorius StedimBiotech Main Business
Table Sartorius StedimBiotech Recent Development
Table Sartorius StedimBiotech Main Business
Table Sartorius StedimBiotech Recent Development
Table Merck Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Merck
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Eppendorf Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Eppendorf
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eppendorf Main Business
Table Eppendorf Recent Development
Table Roche Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Roche
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Nova Biomedicals Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Nova Biomedicals
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Nova Biomedicals Main Business
Table Nova Biomedicals Recent Development
Table Lonza Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Lonza
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lonza Main Business
Table Lonza Recent Development
Table Becton Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of Becton
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Becton Main Business
Table Becton Recent Development
Table and Dickinson and Company Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of and Dickinson and Company
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table and Dickinson and Company Main Business
Table and Dickinson and Company Recent Development
Table GEA Company Profile
Table Biopharmaceutical Buffers Product Introduction, Application and Specification of GEA
Table Biopharmaceutical Buffers Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GEA Main Business
Table GEA Recent Development
Figure Global Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure Global Biopharmaceutical Buffers Revenue and Growth Rate (2017-2022)
Table Global Biopharmaceutical Buffers Sales by Regions (2017-2022)
Figure Global Biopharmaceutical Buffers Sales Market Share by Regions in 2021
Table Global Biopharmaceutical Buffers Revenue by Regions (2017-2022)
Figure Global Biopharmaceutical Buffers Revenue Market Share by Regions in 2021
Figure North America Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure Europe Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure China Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure Japan Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Figure Other Regions Biopharmaceutical Buffers Sales and Growth Rate (2017-2022)
Table Global Biopharmaceutical Buffers Sales by Big Type (2017-2022)
Table Global Biopharmaceutical Buffers Sales Market Share by Big Type (2017-2022)
Figure Global Biopharmaceutical Buffers Sales Market Share by Big Type in 2019
Table Global Biopharmaceutical Buffers Revenue by Big Type (2017-2022)
Table Global Biopharmaceutical Buffers Revenue Market Share by Big Type (2017-2022)
Table Global Biopharmaceutical Buffers Revenue Market Share by Big Type in 2019
Figure Global Sterile Buffer Sales Growth Rate (2017-2022)
Figure Global Sterile Buffer Price (2017-2022)
Figure Global Non-sterile Buffer Sales Growth Rate (2017-2022)
Table Global Biopharmaceutical Buffers Sales by Big Application (2017-2022)
Table Global Biopharmaceutical Buffers Sales Market Share by Big Application (2017-2022)
Figure Global Biopharmaceutical Buffers Sales Market Share by Big Application in 2019
Figure Global Recombinant Proteins Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
Figure Global Antibiotics Sales Growth Rate (2017-2022)
Figure Global Probiotics Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Biopharmaceutical Buffers Sales and Growth Rate (2022-2027)
Figure Global Biopharmaceutical Buffers Revenue and Growth Rate (2022-2027)
Table Global Biopharmaceutical Buffers Sales Forecast by Regions (2022-2027)
Table Global Biopharmaceutical Buffers Market Share Forecast by Regions (2022-2027)
Figure North America Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Figure Europe Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Figure China Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Figure Japan Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Figure Southeast Asia Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Figure Other Regions Sales Biopharmaceutical Buffers Market Forecast (2022-2027)
Table Global Biopharmaceutical Buffers Sales Forecast by Type (2022-2027)
Table Global Biopharmaceutical Buffers Market Share Forecast by Type (2022-2027)
Table Global Biopharmaceutical Buffers Sales Forecast by Application (2022-2027)
Table Global Biopharmaceutical Buffers Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biopharmaceutical Buffers
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Biopharmaceutical Buffers Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Biopharmaceutical Buffers Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Biopharmaceutical Buffers Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Biopharmaceutical Buffers Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Biopharmaceutical Buffers Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Biopharmaceutical Buffers Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Biopharmaceutical Buffers Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Biopharmaceutical Buffers Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)